全文获取类型
收费全文 | 158410篇 |
免费 | 13561篇 |
国内免费 | 6340篇 |
专业分类
耳鼻咽喉 | 800篇 |
儿科学 | 3570篇 |
妇产科学 | 1726篇 |
基础医学 | 25043篇 |
口腔科学 | 3157篇 |
临床医学 | 13448篇 |
内科学 | 27799篇 |
皮肤病学 | 2528篇 |
神经病学 | 12529篇 |
特种医学 | 2508篇 |
外国民族医学 | 30篇 |
外科学 | 9576篇 |
综合类 | 25007篇 |
现状与发展 | 31篇 |
一般理论 | 1篇 |
预防医学 | 9307篇 |
眼科学 | 1801篇 |
药学 | 19838篇 |
62篇 | |
中国医学 | 6706篇 |
肿瘤学 | 12844篇 |
出版年
2024年 | 402篇 |
2023年 | 2240篇 |
2022年 | 4169篇 |
2021年 | 6326篇 |
2020年 | 5435篇 |
2019年 | 4661篇 |
2018年 | 4533篇 |
2017年 | 5008篇 |
2016年 | 5449篇 |
2015年 | 5899篇 |
2014年 | 9777篇 |
2013年 | 10893篇 |
2012年 | 9907篇 |
2011年 | 11017篇 |
2010年 | 8744篇 |
2009年 | 8579篇 |
2008年 | 8650篇 |
2007年 | 8352篇 |
2006年 | 7430篇 |
2005年 | 6898篇 |
2004年 | 5775篇 |
2003年 | 5076篇 |
2002年 | 4083篇 |
2001年 | 3587篇 |
2000年 | 3075篇 |
1999年 | 2640篇 |
1998年 | 2391篇 |
1997年 | 2153篇 |
1996年 | 1847篇 |
1995年 | 1540篇 |
1994年 | 1337篇 |
1993年 | 1143篇 |
1992年 | 1010篇 |
1991年 | 909篇 |
1990年 | 745篇 |
1989年 | 649篇 |
1988年 | 616篇 |
1987年 | 584篇 |
1986年 | 552篇 |
1985年 | 756篇 |
1984年 | 658篇 |
1983年 | 422篇 |
1982年 | 522篇 |
1981年 | 420篇 |
1980年 | 349篇 |
1979年 | 236篇 |
1978年 | 203篇 |
1977年 | 172篇 |
1976年 | 140篇 |
1975年 | 104篇 |
排序方式: 共有10000条查询结果,搜索用时 421 毫秒
1.
《Saudi Pharmaceutical Journal》2022,30(11):1572-1588
Non-alcoholic fatty liver disease (NAFLD) is one of the most common complications of a metabolic syndrome caused by excessive accumulation of fat in the liver. Orthosiphon stamineus also known as Orthosiphon aristatus is a medicinal plant with possible potential beneficial effects on various metabolic disorders. This study aims to investigate the in vitro inhibitory effects of O. stamineus on hepatic fat accumulation and to further use the computational systems pharmacology approach to identify the pharmacokinetic properties of the bioactive compounds of O. stamineus and to predict their molecular mechanisms against NAFLD. Methods: The effects of an ethanolic extract of O. stamineus leaves on cytotoxicity, fat accumulation and antioxidant activity were assessed using HepG2 cells. The bioactive compounds of O. stamineus were identified using LC/MS and two bioinformatics databases, namely the Traditional Chinese Medicine Integrated Database (TCMID) and the Bioinformatics Analysis Tool for the Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM). Pathway enrichment analysis was performed on the predicted targets of the bioactive compounds to provide a systematic overview of the molecular mechanism of action, while molecular docking was used to validate the predicted targets. Results: A total of 27 bioactive compounds corresponding to 50 potential NAFLD-related targets were identified. O. stamineus exerts its anti-NAFLD effects by modulating a variety of cellular processes, including oxidative stress, mitochondrial β-oxidation, inflammatory signalling pathways, insulin signalling, and fatty acid homeostasis pathways. O. stamineus is significantly targeting many oxidative stress regulators, including JNK, mammalian target of rapamycin (mTOR), NFKB1, PPAR, and AKT1. Molecular docking analysis confirmed the expected high affinity for the potential targets, while the in vitro assay indicates the ability of O. stamineus to inhibit hepatic fat accumulation. Conclusion: Using the computational systems pharmacology approach, the potentially beneficial effect of O. stamineus in NAFLD was indicated through the combination of multiple compounds, multiple targets, and multicellular components. 相似文献
2.
《Cancer cell》2022,40(2):153-167.e11
- Download : Download high-res image (229KB)
- Download : Download full-size image
3.
4.
《Vaccine》2022,40(27):3721-3726
We initiated a randomized, placebo-controlled, phase 1/2 trial to evaluate the safety and immunogenicity of the S-268019-b recombinant protein vaccine, scheduled as 2 intramuscular injections given 21 days apart, in 60 randomized healthy Japanese adults. We evaluated 2 regimens of the S-910823 antigen (5 μg [n = 24] and 10 μg [n = 24]) with an oil-in-water emulsion formulation and compared against placebo (n = 12). Reactogenicity was mild in most participants. No serious adverse events were noted. For both regimens, vaccination resulted in robust IgG and neutralizing antibody production at days 36 and 50 and predominant T-helper 1-mediated immune reaction, as evident through antigen-specific polyfunctional CD4+ T-cell responses with IFN-γ, IL-2, and IL-4 production on spike protein peptides stimulation. Based on the interim analysis, the S-268019-b vaccine is safe, produces neutralizing antibodies titer comparable with that in convalescent serum from COVID-19-recovered patients. However, further evaluation of the vaccine in a large clinical trial is warranted. 相似文献
5.
6.
7.
《Cancer cell》2021,39(9):1214-1226.e10
- Download : Download high-res image (204KB)
- Download : Download full-size image
8.
《Vaccine》2022,40(32):4296-4300
Advanced computational methodologies suggested SARS-CoV-2, nonstructural proteins ORF1AB, ORF3a, as the source of immunodominant peptides for T cell presentation. T cell immunity is long-lasting and compatible with COVID-19 pathology. Based on the supporting clinical data, nonstructural SARS-CoV-2 protein vaccines could provide global immunity against COVID-19. 相似文献
9.
10.
《Vaccine》2022,40(32):4440-4452
Coronavirus disease 2019 (COVID-19) is an acute respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The prevention of SARS-CoV-2 transmission has become a global priority. Previously, we showed that a protein subunit vaccine that was developed based on the fusion of the SARS-CoV-2 receptor-binding domain (RBD) to the Fc portion of human IgG1 (RBD-Fc), produced in Nicotiana benthamiana, and adjuvanted with alum, namely, Baiya SARS-CoV-2 Vax 1, induced potent immunological responses in both mice and cynomolgus monkeys. Hence, this study evaluated the protective efficacy, safety, and toxicity of Baiya SARS-CoV-2 Vax 1 in K18-hACE2 mice, monkeys and Wistar rats. Two doses of vaccine were administered three weeks apart on Days 0 and 21. The administration of the vaccine to K18-hACE2 mice reduced viral loads in the lungs and brains of the vaccinated animals and protected the mice against challenge with SARS-CoV-2. In monkeys, the results of safety pharmacology tests, general clinical observations, and a core battery of studies of three vital systems, namely, the central nervous, cardiovascular, and respiratory systems, did not reveal any safety concerns. The toxicology study of the vaccine in rats showed no vaccine-related pathological changes, and all the animals remained healthy under the conditions of this study. Furthermore, the vaccine did not cause any abnormal toxicity in rats and was clinically tolerated even at the highest tested concentration. In addition, general health status, body temperature, local toxicity at the administration site, hematology, and blood chemistry parameters were also monitored. Overall, this work presents the results of the first systematic study of the safety profile of a plant-derived vaccine, Baiya SARS-CoV-2 Vax 1; this approach can be considered a viable strategy for the development of vaccines against COVID-19. 相似文献